Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020

A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estim...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogogiannidou, Zacharoula, Vontas, Alexandros, Dadouli, Katerina, Kyritsi, Maria A, Soteriades, Soteris, Nikoulis, Dimitrios J, Mouchtouri, Varvara Α, Koureas, Michalis, Kazakos, Evangelos I, Spanos, Emmanouil G, Gioula, Georgia, Ntzani, Evangelia E, Eleftheriou, Alexandros A, Vatopoulos, Alkiviadis, Petinaki, Efthimia, Papaevangelou, Vassiliki, Speletas, Matthaios, Tsiodras, Sotirios, Hadjichristodoulou, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2020
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459271/
https://www.ncbi.nlm.nih.gov/pubmed/32762796
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.31.2001369
Descripción
Sumario:A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estimated at 0.02% and 0.25%, respectively, in March and April, infection fatality rate at 2.66% and 0.54%. Our findings confirm low COVID-19 incidence in Greece and possibly the effectiveness of early measures.

Ejemplares similares